BCM

BIOS Capital Management Portfolio holdings

AUM $72.6M
This Quarter Est. Return
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$72.6M
AUM Growth
-$6.6M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
6
New
Increased
Reduced
Closed

Top Buys

1 +$2.53M
2 +$436K

Top Sells

1 +$416K
2 +$6

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACTU
1
Actuate Therapeutics
ACTU
$155M
$60.9M 83.89%
9,965,079
+71,428
IRD
2
Opus Genetics
IRD
$138M
$3.46M 4.77%
3,683,429
+2,688,180
LTRN icon
3
Lantern Pharma
LTRN
$43.3M
$3.4M 4.68%
1,075,952
-131,757
RNTX
4
Rein Therapeutics
RNTX
$37.5M
$2.37M 3.26%
1,690,751
CGTX icon
5
Cognition Therapeutics
CGTX
$158M
$1.86M 2.56%
6,000,000
INAB icon
6
IN8bio
INAB
$8.85M
$599K 0.83%
286,664
-3